Learning Center

Learning Center

Clinical Conundrums & Challenging Cases in the Bone Health of Transgender Individuals (On-demand)

  • Register
    • Non-Member - $25
    • Full Member - Free!
    • MOC Only - $25
    • Community Member - $25
    • Professional Member - $25

Activity approved for 1.00 AMA PRA Category 1 Credits™ 
Activity approved for 1.25 ASRT Category A Credits
Activity Expires May 26, 2026

Activity Description

Transgender and gender diverse (TGD) people are at increased risk for bone loss due to changes in their hormonal milieu. The ISCD recommends screening for low bone density in TGD people especially in those who are at high risk for bone loss and/or may not reach peak bone mass. This case-based session will discuss different clinical situations where bone density screening should be performed and when treatment should be considered.

Learning Objectives:

  1. Review ISCD guidelines for screening for low bone density in transgender and gender diverse people.
  2. List conditions that might put transgender and gender diverse people at increased risk for bone loss.
  3. Discuss potential treatment options for transgender and gender diverse people.

Instructions:

Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

Registration Fees

image

Cancellation Policy

On-Demand/ Enduring Material Cancellation
Purchases of on-demand or enduring educational materials are non-refundable.

On-Demand/Enduring Material Program Changes or Cancellations 
ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Joint Accreditation Statement:

image

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credit(s)™

Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASRT Credit Designation 

This activity is approved by ASRT for 1.25 Category A continuing education credits.*

*This activity may be available in multiple formats. A self-learning activity can be completed only once per biennium.

Date of Original Release and most recent Review or Update 

This activity was most recently reviewed and released on May 27th, 2025.

Vin Tangpricha, MD, PhD

Professor of Medicine, Eminent Physician

Division of Endocrinology, Metabolism & Lipids, Emory University School of Medicine

Vin Tangpricha is a Professor of Medicine in the Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine in Atlanta, Georgia. Dr. Tangpricha received his medical degree from Tufts University School of Medicine and completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center. He completed his PhD in molecular medicine on the topic of vitamin D at Boston University School of Medicine. He serves on the Endocrine Society guidelines committee for the hormone treatment of gender-non-conforming and gender incongruent patients, which has published two international guidelines on transgender patients (2009 and revised in 2017). He served on the World Professional Association for Transgender Health (WPATH) guidelines for the Standards of Care (SOC) for Transgender people as the endocrine section chair. He is the immediate past-president of WPATH. He has received funding from the Cystic Fibrosis Foundation and NIH. He has published over 250 peer reviewed manuscripts on transgender medicine, vitamin D, and cystic fibrosis.

image

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use 

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

Attendee Cancellation Policy

All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

Course Changes or Cancellations

ISCD reserves the right to cancel the program and change the dates of the offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

Components visible upon registration.